- Pfizer’s CEO reportedly postponed a trip to Israel because his entourage wasn’t fully vaccinated.
- The Jerusalem Post and The Times of Israel said members of the CEO’s team had received a first dose.
- CEO Albert Bourla told CNBC previously he wouldn’t “cut the line” for the COVID-19 vaccine.
Pfizer CEO Albert Bourla and his entourage postponed a trip to Israel because they’re not yet fully vaccinated against COVID-19, local reports said.
On Friday, The Jerusalem Post and The Times of Israel reported that local TV news station Channel 12 News said the chief executive’s planned Israel trip was pushed back because Bourla wasn’t yet fully vaccinated.
The reports said Bourla and some members of the team had received their first COVID-19 vaccine shots, but not their second dose.
“We remain interested in meeting the scientific leaders and other important stakeholders who were vital to the successful COVID-19 vaccination program in Israel. Any company visit will likely occur once travel conditions improve and COVID-19-related restrictions are eased,” a Pfizer spokesperson told Insider on Saturday.
Back in December, Bourla told CNBC he wouldn’t “cut the line” to get his company’s coronavirus vaccine, developed in partnership with Germany’s BioNTech.
“I’m 59 years old, in good health, I’m not working on the frontline, so my type it is not recommended to get vaccination now,” he said at the time.
Read the article by Kevin Shalvey in Business Insider Australia.